logo-loader
RNS
GenIP PLC

GenIP PLC - Corporate Update

RNS Number : 2406K
GenIP PLC
30 June 2026
 

 




 

30 June 2026

 

GenIP Plc

("GenIP" or the "Company")

 

Corporate Update

GenIP provides a corporate update following the CEO's visit to the UK for the Company's AGM and meetings with clients, investors and strategic partners in June.

The Company hosted a roundtable discussion bringing together innovation leaders from academia, industry and Government, chaired by Lord David Willetts (Chairman of GenIP) and KEUK, to discuss AI's role in improving R&D outcomes.

Management met with investors, brokers and market participants in a series of meetings and lunches where the Company's strategy and growth plans were discussed, and feedback was welcomed from investors.

Strategy sessions with the UK-based team focused on the next phase of growth and development of GenIP's SaaS subscription platform, which remains on track for Q4 2026, targeting 60%+ gross margins and 90-95% automation by early 2027. The platform will formalise repeat purchasing behaviour already demonstrated across the client base and transition GenIP from a services business to a scalable, recurring revenue intelligence platform.

Leveraging GenIP's proprietary database, the platform has also been enhanced by utilising Anthropic's AI technology as part of its AI workflow to further strengthen the quality, speed and depth of its analysis. As GenIP's data flywheel continues to strengthen, with every client engagement enriching its proprietary dataset, the Company is further optimising its offering and reinforcing its position as a leading provider of AI-powered technology intelligence and data-driven decision support.

The CEO also attended the annual Cambridge Dinner hosted by the London Stock Exchange and law firm Bird & Bird, focused on capital markets, venture capital and corporate growth.

The Company continues to build its global partnership network, with the Cardinal IP referral programme now live, generating initial introductions to leading and Fortune 500 corporates and law firms. Partnerships in Latin America with GreenTech (Chile) and Pelotas (Brazil) are driving academic and government pipeline opportunities across the region, while Asia-Pacific and Middle East expansion is underway, including the appointment of an Asia-based sales resource.

Melissa Cruz, CEO of GenIP, commented:

"It was great to be back in London for two weeks spending time with clients, investors and the team. I leave energised by the conversations we've had and with clear direction for the next phase of GenIP's growth. I'm looking forward to sharing more progress in the months ahead."

 

For further information regarding GenIP, please visit www.genip.ai, or contact:

 

GenIP Plc

Melissa Cruz, CEO 


Via Redchurch Communications




AlbR Capital Limited (Joint Broker) 

Colin Rowbury

Jon Belliss

 

            

Tel: +44 (0)20 7399 9427

cr@albrcapital.com 

Jb@albrcapital.com

 

CMC Markets (Joint Broker)


Tel: + 44 (0) 203 003 8632

Douglas Crippen 



 



Redchurch Communications (Financial PR)

John Casey

 

 


genip@weareredchurch.com

 

 

About Reach announcements

 

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

Notes to Editors

 

About GenIP

 

GenIP is a next-generation business      at the intersection of generative AI and innovation strategy. We empower corporates, venture funds, and research institutions to evaluate, commercialise, and scale breakthrough technologies. By combining proprietary GenAI algorithms with expert human analysis, GenIP delivers decision-grade insights and talent solutions that accelerate innovation outcomes.

 

Service Offerings

 

GenIP operates through two synergistic service lines:

 

 

Service

Description

Value Proposition

Invention Intelligence Product Suite

AI-powered market intelligence reports assessing the commercial potential of emerging technologies

Enables faster, evidence-based decisions on R&D prioritisation, investment, and IP strategy

IP Commercialization Services

 

End-to-end engagement to help research organisations commercialise innovations

 

Provides cost-effective, broad support to achieve our clients' strategic objectives

 

 

Together, these services form a unified GenAI-enabled platform for innovation triage and execution.

 

Vision & Strategy

 

GenIP aims to become the global leader in generative AI analytics for innovation commercialisation. Our strategy is anchored in three growth pillars:

 

●     Organic Expansion
Scale Invention Evaluator and Recruitment Services through targeted outreach to corporates, VCs, and research institutions, supported by strategic marketing and digital engagement.

●     Service Deepening
Enhance functionality and margin by expanding GenAI capabilities within both service lines-unlocking new use cases and customer segments.

●     Strategic Acquisitions
Pursue bolt-on acquisitions of complementary GenAI services with validated market traction to broaden our offering and accelerate growth.

 

Forward looking statements

 

Certain statements contained in this announcement constitute forward-looking statements. When used in this announcement, the words "may", "would", "could", "will", "intend", "plan", "anticipate", "believe", "seek", "propose", "estimate", "expect", and similar expressions, as they relate to the Company, are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding intentions, beliefs or current expectations concerning, among other things, the Company's results of operations, financial position, liquidity, prospects, growth, strategies and expectations of the industry in which the Company operates.

 

Such statements reflect the Company's current views with respect to future events and are subject to certain risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to materially differ from those described in this announcement Should one or more of these risks or uncertainties materialise, or should assumptions underlying forward-looking statements prove incorrect, actual results may differ materially from those described in this announcement as "intended", "planned", "anticipated", "believed", "proposed", "estimated" or "expected".

 

For the avoidance of doubt, the contents of the Company's website and any hyperlinks accessible from the Company's website are not incorporated by reference into, and do not form part of, this announcement and investors should not rely on them.

-ENDS-

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEKLFLQQLEBBX
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

5 min read